Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

AAIPharma Expands Capacity of Parenteral Manufacturing Facility

Published: Friday, December 28, 2012
Last Updated: Thursday, December 27, 2012
Bookmark and Share
Addition of on-site formulation development capabilities and enhanced analytical instrumentation.

AAIPharma Services Corp. has announced that it is expanding the capacity and capabilities of its parenteral manufacturing facility in Charleston, S.C.

Facility expansions currently underway at AAIPharma’s Charleston location include the installation of compounding and aseptic processing suites to contain a newly acquired Monoblock vial filling machine, expansion of the microbiology laboratory and addition of on-site formulation development capabilities and enhanced analytical instrumentation.

“One of AAIPharma’s key offerings is the ability to provide our clients with low line loss techniques,” said Rob Goshert, vice president of sales and client services.

Goshert continued, “We are often challenged by our clients to minimize consumption of their expensive active ingredients, and one way AAIPharma has answered this challenge is through the use of specialized filling processes designed to minimize product loss.”

AAIPharma’s FDA- and EU-approved facility utilizes disposable product contact components and maintains redundant critical capabilities to minimize potential downtime.

The fill and finish capabilities support vial sizes from 2 mL to 50 mL and can include 100% weight check.

Manufactured products include solutions, lyophilized products, emulsions and suspensions with batch sizes ranging from a few hundred vials to twenty-thousand, or more.

“In addition to the new fill line, integration of our formulation development and technical services capabilities through the build-out of a new pilot suite allows us to seamlessly support the manufacturing process from development through scale-up, further enhancing our compound to clinic™ strategy” said Paul Maffuid, Ph.D., vice president of pharmaceutical operations.

Maffuid continued, “Expansion of the existing laboratories with a new clean room for on-site sterility testing using isolator technology continues our primary objective of providing a world-class parenteral manufacturing facility with all supporting infrastructure under one roof.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AAIPharma and CML Announce the Appointments of Vice Presidents
Appointment of Ted Dolan as Vice President, API Operations and Syed T. Husain as Vice President, API Business Unit.
Friday, October 10, 2014
AAIPharma and CML Appoints CEO
Appointment of Stephan Kutzer as Chief Executive Officer, effective August 1, 2014.
Thursday, July 10, 2014
AAIPharma and CML Announce Patrick Walsh’s Resignation as CEO
Both Companies announces the appointment of interim CEO, Susan Nestegard.
Saturday, April 12, 2014
Cambridge Major Laboratories and AAIPharma Services Announce Merger
Merger is expected to close by the end of October 2013.
Thursday, October 03, 2013
AAIPharma Services Acquires Celsis Analytical Services
Combined company creates one of the leading material testing businesses offering a comprehensive range of testing services to numerous industries.
Monday, February 13, 2012
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos